✦ LIBER ✦

Irinotecan and docetaxel as first line chemotherapy in patients with stage IIIB/IV non-small cell lung cancer—experience from a prematurely closed phase II study

✍ Scribed by Raez, Luis E; Rosado, Manuel F; Santos, Edgardo S; Reis, Isildinha M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-4 A randomized phase II study of docet

✍ Groen, H.J.M.; Wachters, F.M.; Biesma, B.; Schramel, F.M.N.H.; Stigt, J.A.; Smit 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 188 KB

A randomised phase II trial of docetaxel

✍ Wachters, F M; Groen, H J M; Biesma, B; Schramel, F M N H; Postmus, P E; Stigt, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB

Gemcitabine plus docetaxel as first-line

✍ Joaquín Casal; Margarita Amenedo; José Ramón Mel; Luis Miguel Antón; Rubén Rodrí 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 343 KB

Phase I/II Trial of Docetaxel and Carbop

✍ Kensuke Kataoka; Ryujiro Suzuki; Hiroyuki Taniguchi; Yasunobu Noda; Joe Shindoh; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 82 KB

P-207 Docetaxel and irinotecan as first

✍ Groth, Gesine; Reck, Martin; Wilke, Hansjochen; Büchele, Thomas; Schäfer, Klaus; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 421 KB

Weekly chemotherapy with carboplatin, do

✍ D Pectasides; A Visvikis; A Kouloubinis; J Glotsos; N Bountouroglou; N Karvounis 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 115 KB